• Explore /
  • Poster
  • / Umbrella protocol for phase I/IIa trials of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter methylation Neuro Master Match (N²M²).

Umbrella protocol for phase I/IIa trials of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter methylation Neuro Master Match (N²M²).

Abstract Poster

Authors

null

Anne Hertenstein

Heidelberg University Hospital, German Cancer Research Center (DKFZ), Heidelberg, DE, Germany

Anne Hertenstein , David Jones , Felix Sahm , Elke Pfaff , Barbara Hutter , Irini Karapanagiotou-Schenkel , Andreas Eisenmenger , Matthias Osswald , Antje Wick , Sarah Loew , Martin Bendszus , Juergen Debus , Christel Herold-Mende , Andreas Unterberg , Andreas von Deimling , Benedikt Brors , Michael Platten , Stefan M. Pfister , Wolfgang Wick

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Central Nervous System Tumors

Citation

J Clin Oncol 34, 2016 (suppl; abstr TPS2084)

DOI

10.1200/JCO.2016.34.15_suppl.TPS2084

Abstract #

TPS2084

Poster Bd #

268a

Abstract Disclosures

Similar Posters

First Author: Louis B. Nabors

Poster

2020 ASCO Virtual Scientific Program

Phase III TRIDENT trial: Radiation and temozolomide +/- tumor treating fields in newly diagnosed glioblastoma.

Phase III TRIDENT trial: Radiation and temozolomide +/- tumor treating fields in newly diagnosed glioblastoma.

First Author: Wenyin Shi

First Author: Warren P. Mason

First Author: Jiayi Huang